Clinical Trials Browser

Phase 2 × NIH × tanespimycin × Clear all

NCT00118092 2017-04-18

17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Phase 2 Completed

17 enrolled 6 charts

Prostatic Neoplasms

NCT00118248 2017-02-15

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

Phase 2 Completed

41 enrolled 10 charts

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary

NCT00096109 2017-01-16

Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer

Phase 2 Terminated

11 enrolled 6 charts

Breast Neoplasms

NCT00082966 2015-12-04

Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Phase 2 Completed

Hodgkin Disease

NCT00577889 2014-07-25

Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer

Phase 2 Completed

21 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00117988 2014-05-30

17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

Phase 2 Completed

22 enrolled 5 charts

Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

NCT00104897 2013-06-26

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma

Phase 2 Completed

Melanoma

NCT00093405 2013-06-24

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00087386 2013-04-10

Tanespimycin in Treating Patients With Stage III-IV Melanoma

Phase 2 Terminated

Melanoma

NCT00088374 2012-07-27

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

Phase 2 Completed

9 enrolled 8 charts

Carcinoma, Renal Cell, von Hippel-Lindau Disease, Kidney Neoplasms

NCT00132015 2012-03-15

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Phase 2 Completed

LymphoidMyeloidOther hematologic neoplasmOther neoplasm

Multi-centric Castleman's Disease, Angiolymphoid Hyperplasia with Eosinophilia, Burkitt Lymphoma, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma